Cquin Syrup

About Cquin 80 mg/5 ml Syrup

Cquin 80 mg/5 ml is a syrup product of Opsonin Pharma Limited that contains Chloroquine Phosphate. Only a doctor can confirm which of these conditions applies to a patient and whether this medicine is appropriate.

There are 24 brands of Chloroquine Phosphate listed in Bangladesh. The lowest listed price is Jasochlor 250 mg Tablet at ৳ 1.21 per unit.

What is Cquin 80 mg/5 ml Syrup?

Cquin 80 mg/5 ml syrup is a medicine made by Opsonin Pharma Limited. Always use it under medical supervision, as the doctor will decide the right course for your condition. It is used for treating and preventing malaria, and also for amoebic hepatitis, amoebic abscess, discoid and systemic lupus erythematosus, and rheumatoid arthritis. Always follow medical advice and do not self-medicate.

Uses of Cquin

Only a doctor can confirm which of these conditions applies to a patient and whether this medicine is appropriate. Only a doctor can decide if this medicine is suitable for a particular person and for which condition it is being prescribed. It is also used for amoebic hepatitis and amoebic abscess, which are liver infections. Ask your doctor or pharmacist if you are unsure why it has been prescribed for you.

How to use Cquin

Store at room temperature in a dry place, away from light. Measure the liquid with the cap or spoon that comes with the pack. Cquin is taken by mouth. Take Cquin as your doctor tells you. Always follow the doctor's instructions exactly and do not change the amount on your own. Do not change the amount or stop the medicine without asking the doctor.

Side effects of Cquin

Most people tolerate Cquin 80 mg/5 ml syrup well at the prescribed dose. The most serious risk of long treatment is eye damage, which may not be reversible. Headache and stomach or bowel upset may occur and are usually not serious. Tell your doctor about any unusual symptoms. Contact your doctor if you notice any side effects.

Safety and precautions

People who need long-term treatment may need eye checks as advised by the doctor. Before using Cquin syrup, tell your doctor if you have liver problems, especially if you also have porphyria, or if you drink alcohol regularly. Keep out of reach of children.

Frequently asked questions

What does Cquin treat?

Only a doctor can confirm which of these conditions applies to a patient and whether this medicine is appropriate. Only a doctor can decide if this medicine is suitable for a particular person and for which condition it is being prescribed.

How is Cquin used?

Store at room temperature in a dry place, away from light. Measure the liquid with the cap or spoon that comes with the pack.

What should I watch for while using Cquin?

Most people tolerate Cquin 80 mg/5 ml syrup well at the prescribed dose. The most serious risk of long treatment is eye damage, which may not be reversible.

Can I use Cquin in pregnancy or while breastfeeding?

People who need long-term treatment may need eye checks as advised by the doctor. Before using Cquin syrup, tell your doctor if you have liver problems, especially if you also have porphyria, or if you drink alcohol regularly.

Also available as

250 mg (Tablet)

Indications

Chloroquine Phosphate is indicated in the following cases:
  • Treatment of malaria
  • Prophylaxis and suppression of malaria
  • Treatment of amoebic hepatitis and abscess
  • Treatment of discoid and systemic and systemic lupus erythematosus
  • Treatment of rheumatoid arthritis

Pharmacology

Chloroquine is used for malarial prophylaxis (as a suppressive) and in managing acute attacks of malaria. It is highly active against erythrocytic forms of P. vivax, P. malariae and P. falciparum. It influences Hb digestion by increasing intravesicular pH in malaria parasite cells and interferes with the nucleoprotein synthesis of the patient. It is also effective in extra intestinal amoebiasis. In RA chloroquine and more effectively hydroxychloroquine have a disease-modifying effect.

Dosage & Administration

Treatment of Malaria-

Partially immune adults:

A single dose of 4 tablets. In severe attacks, the dosage schedule for non-immune adults should be adopted.

Partially immune children:

  • Under 1 year: 1-2 single dose (in 5 ml spoonful)
  • 1-3 years: 3-4 single dose (in 5 ml spoonful)
  • 3-6 years: 4-6 single dose (in 5 ml spoonful)
  • 6-9 years: 6-9 single dose (in 5 ml spoonful)
In severe attacks, the dosage schedule for non-immune children should be adopted.

Non-immune adults:

  • P. falciparum infections: 4 tablets initially, 2 tablets after 6 to 8 hours and then 2 tablets per day for 2 days
  • P. vivax group infections: A single dose of four tablets followed by a course of treatment with primaquine phosphate (15 mg base daily for fourteen days)

Non-immune Children:

Under 1 year:
  • 1-2 initial dose (in 5 ml spoonful)
  • 1 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
1-3 years:
  • 3-4 initial dose (in 5 ml spoonful)
  • 1-2 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
3-6 years:
  • 4-6 initial dose (in 5 ml spoonful)
  • 2-3 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)
6-9 years :
  • 6-9 initial dose (in 5 ml spoonful)
  • 3-5 dose to be taken 6 hours later and then daily for 2 days (in 5 ml spoonful)

Prophylaxis and suppression of Malaria-

Adults: 2 tablets taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.

Children (Syrup): The following doses should be taken once a week, on the same day each week, during exposure to risk and continued for 6 weeks after leaving the malarious area.
  • Under 1 year: 1 single dose (in 5 ml spoonful)
  • 1-3 years: 2 single dose (in 5 ml spoonful)
  • 3-6 years: 2-3 single dose (in 5 ml spoonful)
  • 6-9 years: 3-5 single dose (in 5 ml spoonful)
Children (Tablets): For practical purpose, children over 12 years may be treated as adults and for those below this age, the following proportions may be applied.
  • Under 1 year: ⅛ adult dose (¼ tablet)
  • 1-4 years: ¼ adult dose (½ tablet)
  • 4-8 years: ½ adult dose (1 tablet)
  • 8-12 years: ¾ adult dose (1.5 tablet)

Interaction

Concomitant therapy with phenylbutazone predisposes to dermatitis, antagonises effect of neostigmine and pyridostigmine, reduces bioavailability of ampicillin. Cimetidine inhibits metabolism of chloroquine raising plasma levels.

Contraindications

There is no absolute contraindication to the use of chloroquine.

Side Effects

Choroquine is well tolerated at the standard dosage regimens, side effects such as headache and gastrointestinal disturbances which may occur are not of a serious nature. Where prolonged high dose is required side effects can be of greater severity and patients may develop skin eruptions, occasional depigmentation or loss of hair, difficulty in accommodation, blurring of vision. Corneal opacities disappear completely when the drug is stopped. Rarely thrombocytopenia, agranulocytosis and aplastic anemia have been reported.

The most serious toxic hazard of prolonged therapy with doses is the occasional development of irreversible retinal damage. For this reason considerable caution is needed in the use of choroquine for long-term high dosage therapy and such use should only be considered when no other drug is available. Defects in visual accommodation may occur on first taking choloquine and patients should be warned regarding driving or operating machinery.

Pregnancy & Lactation

As with all other drugs, the use of choroquine during pregnancy should be avoided if possible, unless in the case of threatening infections, in the judgment of the physician, when the potential benefit outweighs the risk.

Precautions & Warnings

Caution is necessary when giving choroquine to patients with porphyria who also have hepatic dysfunction or cirrhosis as the drug may precipitate severe constitutional symptoms and an increase in the amount of porphyrins excreted in the urine. This reaction is especially apparent in alcoholics. Patients receiving choloquine continuously at higher dose levels for a period longer than 12 months or at weekly intervals for a period of more than 3 years as prophylactic against malaria (or the consumption exceeds 1.6 g/Kg) should undergo ophthalmic examination at three months interval.

Storage Conditions

Store at room temperature in a dry place, away from light.

Alternative brands of Chloroquine Phosphate

Other brands with the same generic name, cheapest first.

See all 24 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.